MCM3AP-AS1: A LncRNA Participating in the Tumorigenesis of Cancer Through Multiple Pathways

Mini Rev Med Chem. 2022;22(16):2138-2145. doi: 10.2174/1389557522666220214100718.

Abstract

Background: More and more shreds of evidence show that the occurrence and development of tumors are closely related to the abnormal expression of LncRNA. A large number of experiments have found that overexpression or under-expression of MCM3AP-AS1 can affect the occurrence and development of cancer cells in varying degrees, such as proliferation, invasion, and translocation. Besides, MCM3AP-AS1 may become a promising target for many tumor biotherapies. This article reviews the pathophysiological functions and molecular mechanisms of MCM3AP-AS1 in various tumors.

Methods: This paper systematically summarizes the published literatures in PubMed. The molecular mechanism of MCM3AP-AS1 in a variety of tumors is reviewed.

Results: The abnormal expression of MCM3AP-AS1 in different tumors is closely related to tumor proliferation, invasion, and migration. MCM3AP-AS1 mediates or participates in related signaling pathways to regulate the expression of targeted miRNAs and proteins. MCM3AP-AS1 plays a vital role in tumor diagnosis and treatment.

Conclusion: LncRNA MCM3AP-AS1 is a feasible tumor marker and a potential therapeutic target for many kinds of tumors.

Keywords: Long non-coding RNA; MCM3AP-AS1; biomarkers; cancer; prognosis; treatment.

Publication types

  • Review

MeSH terms

  • Acetyltransferases / genetics
  • Carcinogenesis* / genetics
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics
  • MicroRNAs* / genetics
  • Neoplasms* / genetics
  • RNA, Long Noncoding* / genetics

Substances

  • Intracellular Signaling Peptides and Proteins
  • MicroRNAs
  • RNA, Long Noncoding
  • Acetyltransferases
  • MCM3AP protein, human